Results 141 to 150 of about 20,782 (204)

Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Open Forum Infect Dis
Cutshaw MK, Harding M, Davenport CA, Okeke NL.   +3 more
europepmc   +1 more source

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts. [PDF]

Open Forum Infect Dis, 2021
Monroe AK, Levy ME, Greenberg AE, Keruly JC, Moore RD, Horberg MA, Kulie P, Mohanraj BS, Kumar PN, Castel AD, DC Cohort Executive Committee .   +10 more
europepmc   +1 more source

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV

, 2015
Victor Valcour, Serena Spudich, Napapon Sailasuta, Nittaya Phanuphak, Sukalaya Lerdlum, James L. K. Fletcher, Eugène Kroon, Linda L. Jagodzinski, Isabel Elaine Allen, Collin L. Adams, Peeriya Prueksakaew, Bonnie M. Slike, Joanna Hellmuth, Jerome H. Kim, Jintanat Ananworanich, SEARCH 010/RV 254 Study Group   +15 more
openalex   +2 more sources

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression. [PDF]

Pharmaceuticals (Basel)
Sayyed SK, Quraishi M, Prabakaran DS, Chandrasekaran B, Ramesh T, Rajasekharan SK, Raorane CJ, Sonawane T, Ravichandran V.   +8 more
europepmc   +1 more source

Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study. [PDF]

Antimicrob Agents Chemother, 2022
Underwood M, Horton J, Nangle K, Hopking J, Smith K, Aboud M, Wynne B, Sievers J, Stewart EL, Wang R.   +9 more
europepmc   +1 more source

Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIV

, 2020
Jane A. O’Halloran, John M. Sahrmann, Anne M. Butler, Margaret A. Olsen, William G. Powderly   +4 more
openalex   +2 more sources

Reply to Dr Martinez: Refining Our Understanding of the Association Between Integrase Inhibitor Therapy and Elevations in Blood Pressure. [PDF]

Clin Infect Dis
Nyein PP, Petoumenos K, Dharan NJ, Hanson J, Matthews GV.   +4 more
europepmc   +1 more source

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. [PDF]

Clin Infect Dis, 2023
Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem V, Günthard HF, Zangerle R, Smith C, Castagna A, d'Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM, RESPOND (International Cohort Consortium of Infectious Diseases) Study Group.   +32 more
europepmc   +1 more source

Allosteric HIV‐1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter‐subunit interactions: Structural and thermodynamic modeling studies [PDF]

, 2016
Nanjie Deng, Ashley C. Hoyte, Yara E. Mansour, Mosaad S. Mohamed, James R. Fuchs, Alan Engelman, Mamuka Kvaratskhelia, Ronald M. Levy   +7 more
openalex   +1 more source

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment. [PDF]

Clin Infect Dis, 2021
Pyngottu A, Scherrer AU, Kouyos R, Huber M, Hirsch H, Perreau M, Yerly S, Calmy A, Cavassini M, Stöckle M, Furrer H, Vernazza P, Bernasconi E, Günthard HF, Swiss HIV Cohort Study.   +14 more
europepmc   +1 more source